Isomorphic Labs raises $5 billion to move drugs into clinical trials
AI startup Isomorphic Labs, spun out of DeepMind in 2021, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital. The funds will go toward developing its drug design engine and advancing candidates into clinical trials. The company did not disclose its valuation.
Sardor Qodirov